Hennessy K D, Green-Hennessy S
Office of Health Policy, U.S. Department of Health and Human Services, Washington, DC 20201, USA.
J Ment Health Adm. 1997 Summer;24(3):340-9. doi: 10.1007/BF02832667.
The growth of managed care has led to greater cost consciousness in the financing and delivery of mental health and substance abuse services. The authors examine whether pressures to reduce the costs associated with mental health and substance abuse treatment have led to the overapplication of a popular managed care strategy, utilization review (UR), to the management of outpatient psychotherapy benefits. Several arguments are presented highlighting why changing outpatient psychotherapy UR practices would be in the best economic and clinical interests of all involved parties, including payers, managed care organizations (MCOs), mental health consumers, and providers. A number of alternatives to the aggressive management of outpatient psychotherapy benefits are outlined and discussed.
管理式医疗的发展使得在心理健康和药物滥用服务的融资与提供方面更具成本意识。作者们研究了降低心理健康和药物滥用治疗相关成本的压力是否导致一种流行的管理式医疗策略——利用审查(UR)——在门诊心理治疗福利管理中的过度应用。文中提出了几个论点,强调为何改变门诊心理治疗的利用审查做法符合所有相关方(包括付款方、管理式医疗组织(MCO)、心理健康消费者和提供者)的最佳经济和临床利益。概述并讨论了积极管理门诊心理治疗福利的一些替代方案。